Back to Agenda
IBM Innovation Theater: Embracing Hybrid - How New Technologies, Synergized with Proven Solutions, Will Shape the Journey to Commonplace Decentralized Trials
Session Chair(s)
Merative
, United States
While all eyes are on decentralized trial technologies to improve patient centricity, it's important to recognize the critical role that hybrid trials plays as our industry is still adapting to changes from the past two years. Join IBM Watson Health to learn how IBM clinical development users have leveraged both new decentralized trial technologies and proven cloud-based solutions to manage highly-successful hybrid trials with record-breaking cycle time.
Speaker(s)
Walker Bradham
Sr Director, Product Management & Design, Zelta by Merative, United States
Wes Fishburne
Senior Product Manager, Zelta by Merative, United States
Mark Laney
Sales Engineering & Product Partnerships Lead, Merative, United States
Have an account?
